VRTX Revenue 2026

Annual and quarterly sales data for Vertex Pharmaceuticals Inc

Latest Annual Revenue

$12.00B

2025-12-31

YoY Growth

+8.9%

vs. previous year

4-Year CAGR

5.0%

compound growth

Annual Revenue History

2025-12-31

$12.00B

YoY Growth

+8.9%

2024-12-31

$11.02B

YoY Growth

+0.0%

2024-12-31

$11.02B

YoY Growth

+11.7%

2023-12-31

$9.87B

YoY Growth

+0.0%

2023-12-31

$9.87B

Quarterly Revenue Breakdown

2026-03-31

$2.99B

2025-09-30

$3.08B

2025-09-30

$3.08B

2025-06-30

$2.96B

2025-06-30

$2.96B

2025-03-31

$2.77B

2025-03-31

$2.77B

2024-09-30

$2.77B

Revenue by Segment

Total Revenue$12.00B (100.0%)

Get Full VRTX Financial Analysis

View complete income statements, balance sheets, and AI-powered insights

Frequently Asked Questions

What is VRTX's revenue?

VRTX (Vertex Pharmaceuticals Inc) reported $12.00 billion in revenue for 2025-12-31. This represents a 8.9% increase compared to the previous year.

How much revenue does VRTX make per year?

Vertex Pharmaceuticals Inc generates approximately $12.00 billion in annual revenue based on the most recent fiscal year ending 2025-12-31.

Is VRTX revenue growing?

Yes, VRTX's revenue is growing. The company achieved 8.9% revenue growth year-over-year. Over the past 4 years, revenue has grown at a compound annual growth rate (CAGR) of 5.0%.

What is VRTX's quarterly revenue?

VRTX reported $2.99 billion in revenue for the most recent quarter (2026-03-31).

What are VRTX's revenue sources?

VRTX's revenue comes from multiple segments: Total Revenue. See the revenue breakdown below for detailed segment analysis.

How does VRTX compare to competitors in revenue?

VRTX generates $12.00 billion in annual revenue in the Healthcare sector. Compare VRTX to competitors using our stock comparison tool to see relative market share and growth rates.

What is VRTX's revenue per share?

Revenue per share for VRTX can be calculated by dividing annual revenue by shares outstanding. Visit our stock analysis page for detailed metrics.

Why is VRTX's revenue important for investors?

Revenue (also called sales or top-line) is the total income Vertex Pharmaceuticals Inc generates from its operations. Revenue growth indicates business expansion and market share gains. For VRTX, tracking revenue trends helps investors understand the company's growth trajectory, pricing power, and market position in the Healthcare sector.

What affects VRTX's revenue growth?

Key factors affecting VRTX's revenue include: market demand, pricing strategy, competitive dynamics, product/service mix, geographic expansion, and macroeconomic conditions.

How to analyze VRTX's revenue quality?

To assess VRTX's revenue quality, consider: (1) Revenue consistency - is growth sustainable? (2) Revenue sources - diversified or concentrated? (3) Recurring vs one-time revenue - subscription models are more predictable. (4) Customer concentration - dependency on few customers. (5) Currency exposure for international operations.

Disclaimer: Revenue data is based on publicly filed financial statements. Historical performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.

Explore Categories